查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085399

冠狀動脈疾病治療器材市場：2026-2032年全球市場預測（依器材類型、材質成分、治療方法、入路及最終用戶分類）

Coronary Artery Disease Treatment Devices Market by Device Type, Material Composition, Treatment Type, Approach, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，冠狀動脈疾病治療設備的市場規模將達到 72.6 億美元，年複合成長率為 5.94%。

主要市場統計數據
基準年 2025 48.4億美元
預計年份：2026年 51.3億美元
預測年份 2032 72.6億美元
複合年成長率 (%) 5.94%

冠狀動脈疾病治療裝置是現代心血管醫學的核心，包括藥物釋放型支架、裸金屬支架、球囊導管、動脈粥狀硬化斑塊切除術系統、血栓除去裝置切除裝置、血管內影像平台、壓力導管導引線、栓塞預防裝置以及經皮冠狀動脈介入治療 (PCI) 和外科血管重組中使用的輔助技術。

全球缺血性心臟疾病負擔沉重，是推動血管介入治療需求的主要因素。世界衛生組織（WHO）指出，缺血性心臟疾病仍是全球首要死因。儘管人口老化、糖尿病、肥胖、高血壓、吸煙以及導管檢查室普及等因素導致手術量持續成長，但臨床指南越來越強調基於循證醫學的病變評估、最佳藥物治療以及針對每位患者的個體化重組策略。

冠狀動脈裝置領域的變革性變化

冠狀動脈疾病治療器材的格局正從單純的機械通暢轉向精準的重組。與傳統支架相比，新一代藥物釋放型支架具有更細的支架梁、生物相容性聚合物和改進的輸送系統，可降低血管再阻塞和支架內血栓症的風險；同時，藥物塗層球囊為某些患者的支架內再血管再阻塞和小血管疾病提供了更多治療選擇。

人工智慧對CAD設備的累積影響

人工智慧（AI）正對冠狀動脈疾病治療的整體產生累積影響，從風險分層到影像診斷、導管室手術計劃、手術輔助以及術後監測。利用人工智慧分析冠狀動脈CT血管攝影檢查、血管造影術、血管內超音波（IVUS）和光學相干斷層掃描（OCT）影像，可以幫助量化斑塊負荷、識別高風險解剖結構，並促進臨床醫生對檢查觀察進行更一致的解讀。

關於冠狀動脈疾病治療設備的關鍵區域見解

亞太地區是冠狀動脈疾病治療器材的高成長區域，這得益於其龐大的病患群體、快速發展的醫院基礎設施，以及中國、印度、日本、韓國和澳洲等國經皮冠狀動脈介入治療（PCI）的日益普及。北美憑藉其先進的導管室設施、完善的保險報銷體系、受美國食品藥物管理局（FDA）監管的創新路徑，以及血管內成像和生理指標介入技術的廣泛應用，繼續保持技術領先地位。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

隨著介入性心臟病學、心血管篩檢以及三級醫療機構的普及，東協市場在印尼、泰國、越南、馬來西亞、菲律賓和新加坡的重要性日益凸顯。海灣合作理事會（GCC）地區的特點是心血管代謝風險高、醫院投資力度大，以及主要大都市地區對高品質心血管技術的偏好，這些因素進一步推動了對先進支架、影像系統和複雜經皮冠狀動脈介入治療（PCI）輔助設備的需求。

主要國家冠狀動脈疾病治療設備的發展趨勢

美國在冠狀動脈高價值治療器械的使用方面處於世界領先地位，這得益於其大量的經皮冠狀動脈介入治療（PCI）手術、先進的影像技術應用、橈動脈入路的普及以及積極的臨床研究。加拿大強調治療效果的品質和嚴格的公共醫療保險報銷制度，而墨西哥和巴西則透過公私混合醫療體系和三級醫療機構的發展，擴大介入治療的覆蓋範圍。英國、德國、法國、義大利和西班牙透過指南實施、國家採購、系統性註冊登記以及強大的循環系統學會，持續影響歐洲的醫療實踐。

為行業領導者提供的實用建議

對於複雜經皮冠狀動脈介入治療（PCI）、糖尿病、小血管病變、鈣化病變、分叉病變以及高出血風險的患者，行業領導者應優先考慮差異化的臨床證據，例如隨機試驗、註冊研究數據和真實世界臨床結果。證據的產生應與衛生經濟模型結合，以證明可降低重組、縮短住院時間、併發症並降低長期照護成本。

市場和臨床洞察的調查方法

本執行摘要綜合運用了檢驗的二級研究、臨床指南審查、監管資訊、公共衛生數據、同行評審文獻、流行病學資料庫和手術趨勢分析。主要參考文獻包括來自公共衛生機構的全球心血管疾病數據、心臟病學會的建議、醫療設備法規結構以及已發表的經皮冠狀動脈介入治療（PCI）技術證據。

結論：冠狀動脈疾病（CAD）治療器材的策略展望

冠狀動脈疾病治療器材領域正朝著精準、實證、數位化支持的重組方向發展。這一發展勢頭是由缺血性心臟疾病持續存在的沉重負擔、治療機會的擴大以及支架、球囊、動脈粥狀硬化斑塊切除術、血栓切除術、影像學和生理引導工具等方面的持續創新所推動的。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 冠狀動脈疾病治療器材市場：依器械類型分類

  • 動脈粥狀硬化斑塊切除術裝置
    • 雷射動脈動脈粥狀硬化斑塊切除術
    • 眼眶動脈粥狀動脈粥狀硬化斑塊切除術
    • 旋切動脈粥狀硬化斑塊切除術
  • 球囊導管
    • 切割球囊導管
    • 藥物塗層球囊導管
    • 標準球囊導管
  • 血管內成像系統
    • 部分血流儲備
    • 血管內超音波
    • 光學同調斷層掃描
  • 支架系統
    • 裸金屬支架
    • 藥物釋放型支架

第8章：冠狀動脈疾病治療器材市場：依材質組成分類

  • 金屬
    • 不銹鋼
    • 鈷鉻合金
    • 鉑金鉻
  • 聚合物
  • 生物可吸收
    • 鎂合金
    • 聚左旋乳酸

第9章：冠狀動脈疾病治療器材市場：依治療類型分類

  • 冠狀動脈繞道手術手術
    • 非泵送
    • 泵浦上法
  • 經皮冠狀動脈介入治療

第10章：冠狀動脈疾病治療器材市場：依治療途徑分類

  • 股動脈路徑
  • 橈動脈入路

第11章：冠狀動脈疾病治療器材市場：依最終用戶分類

  • 門診手術中心
  • 心臟中心
  • 醫院和診所

第12章 冠狀動脈疾病治療器材市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 冠狀動脈疾病治療器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 冠狀動脈疾病治療器材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Abiomed, Inc.
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical Inc.
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services Inc.
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Shockwave Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
  • Zylox-Tonbridge Medical Technology Co., Ltd.
Product Code: MRR-4311CE1A33CA

The Coronary Artery Disease Treatment Devices Market is projected to grow by USD 7.26 billion at a CAGR of 5.94% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.84 billion
Estimated Year [2026] USD 5.13 billion
Forecast Year [2032] USD 7.26 billion
CAGR (%) 5.94%

Coronary artery disease treatment devices are central to modern cardiovascular care, spanning drug-eluting stents, bare-metal stents, balloon catheters, atherectomy systems, thrombectomy devices, intravascular imaging platforms, pressure guidewires, embolic protection devices, and adjunctive technologies used in percutaneous coronary intervention and surgical revascularization.

Demand is anchored by the global burden of ischemic heart disease, which remains the world's leading cause of death according to the World Health Organization. Aging populations, diabetes, obesity, hypertension, tobacco exposure, and improved access to catheterization laboratories continue to sustain procedural volumes, while clinical guidelines increasingly emphasize evidence-based lesion assessment, optimal medical therapy, and patient-specific revascularization strategies.

Transformative Shifts in the Coronary Device Landscape

The coronary artery disease treatment devices landscape is shifting from purely mechanical vessel opening toward precision revascularization. New-generation drug-eluting stents with thinner struts, biocompatible polymers, and improved deliverability have reduced restenosis and stent thrombosis compared with earlier platforms, while drug-coated balloons are expanding options for in-stent restenosis and small-vessel disease in selected patients.

Hospitals and cardiology networks are also adopting intravascular ultrasound, optical coherence tomography, and fractional flow reserve or non-hyperemic pressure ratio tools to improve lesion selection and stent optimization. At the same time, value-based purchasing, same-day discharge pathways after PCI, and growing use of radial access are reshaping procurement priorities toward safety, workflow efficiency, and total cost of care.

Cumulative Impact of Artificial Intelligence on CAD Devices

Artificial intelligence is becoming a cumulative force across coronary artery disease treatment, beginning with risk stratification and extending into imaging, cath lab planning, procedural support, and post-procedure monitoring. AI-enabled analysis of coronary CT angiography, angiograms, IVUS, and OCT can help quantify plaque burden, identify high-risk anatomy, and support more consistent interpretation across operators.

In device markets, AI is also improving operational performance through predictive maintenance, inventory optimization, clinical trial enrichment, and real-world evidence generation. The strongest near-term impact is expected where AI augments clinician decision-making without replacing established guideline-based practice, particularly in lesion assessment, stent sizing, restenosis prediction, and longitudinal follow-up of high-risk patients.

Key Regional Insights for CAD Treatment Devices

Asia-Pacific is a high-growth region for coronary artery disease treatment devices due to large patient pools, rapid hospital infrastructure expansion, and rising adoption of PCI in China, India, Japan, South Korea, and Australia. North America remains a technology leadership hub, supported by advanced cath lab capacity, structured reimbursement, FDA-regulated innovation pathways, and high use of intravascular imaging and physiology-guided intervention.

Europe benefits from mature cardiovascular care networks and guideline-driven adoption of drug-eluting stents, drug-coated balloons, and imaging-guided PCI, with Germany, France, Italy, Spain, and the United Kingdom shaping procedural standards. Latin America is expanding access through private hospital investment and public procurement, led by Brazil and Mexico. The Middle East is investing in tertiary cardiac centers, particularly in GCC markets with high cardiometabolic risk, while Africa shows long-term potential as catheterization infrastructure, specialist training, and device availability improve.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are gaining importance as Indonesia, Thailand, Vietnam, Malaysia, the Philippines, and Singapore improve access to interventional cardiology, cardiovascular screening, and tertiary hospital services. The GCC is characterized by high cardiometabolic risk, strong hospital investment, and preference for premium cardiovascular technologies in major urban centers, reinforcing demand for advanced stents, imaging systems, and complex PCI support devices.

The European Union supports device adoption through harmonized regulatory oversight under the Medical Device Regulation, although clinical evidence and post-market surveillance requirements have increased market entry complexity. BRICS countries combine large ischemic heart disease burden with expanding domestic manufacturing, procurement localization, and broader cath lab capacity. G7 nations remain key innovation, reimbursement, and clinical evidence markets, while NATO-aligned healthcare systems are creating demand for resilient medical supply chains, cybersecurity-ready digital platforms, and diversified sourcing for critical cardiovascular devices.

Key Country Insights for Coronary Artery Disease Treatment Devices

The United States leads in high-value coronary device utilization, supported by large PCI volumes, advanced imaging use, radial access adoption, and active clinical research. Canada emphasizes quality outcomes and public reimbursement discipline, while Mexico and Brazil are expanding interventional access through mixed public-private systems and growing tertiary care capacity. The United Kingdom, Germany, France, Italy, and Spain continue to influence European practice through guideline implementation, national procurement, structured registries, and strong cardiology societies.

Russia maintains demand through centralized hospital networks but faces procurement and supply-chain complexity. China is scaling domestic stent and catheter production while expanding advanced PCI capacity and hospital access. India combines high disease burden with price-sensitive procurement and rapid cath lab growth. Japan and South Korea are advanced technology adopters with strong operator expertise, high procedural quality expectations, and established use of intravascular imaging, while Australia maintains a mature, outcomes-focused cardiovascular device environment supported by evidence-based reimbursement and specialist cardiac networks.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated clinical evidence, including randomized trials, registry data, and real-world outcomes for complex PCI, diabetes, small-vessel disease, calcified lesions, bifurcation lesions, and high bleeding-risk patients. Evidence generation should be paired with health-economic models that demonstrate reductions in repeat revascularization, hospital stay, complications, and long-term care costs.

Manufacturers should invest in AI-enabled imaging partnerships, physician training, supply-chain resilience, cybersecurity readiness, and region-specific pricing strategies. Winning portfolios will integrate stents, balloons, atherectomy, thrombectomy, imaging, physiology, and digital workflow tools into procedure-ready solutions that help hospitals improve outcomes while managing reimbursement pressure and procurement scrutiny.

Research Methodology for Market and Clinical Insights

This executive summary is based on triangulation of verified secondary research, clinical guideline review, regulatory intelligence, public health data, peer-reviewed literature, epidemiology databases, and procedure trend analysis. Core references include global cardiovascular disease data from public health authorities, cardiology society recommendations, medical device regulatory frameworks, and published evidence on PCI technologies.

The methodology emphasizes cross-validation across disease burden, technology adoption, reimbursement conditions, regulatory requirements, and regional healthcare capacity. Insights were structured to support strategic planning for coronary artery disease treatment device manufacturers, distributors, investors, hospital procurement teams, and innovation partners operating across developed and emerging cardiovascular markets.

Conclusion: Strategic Outlook for CAD Treatment Devices

The coronary artery disease treatment devices landscape is advancing toward precision, evidence-based, and digitally supported revascularization. Momentum is supported by persistent ischemic heart disease burden, rising procedural access, and continuous innovation across stents, balloons, atherectomy, thrombectomy, imaging, and physiology-guided tools.

Future leadership will depend on clinical differentiation, affordability, regulatory readiness, supply-chain resilience, and integration with AI-enabled decision support. Organizations that align innovation with measurable patient outcomes, cath lab efficiency, and regional access needs will be best positioned to compete in the evolving global CAD treatment ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Coronary Artery Disease Treatment Devices Market, by Device Type

  • 7.1. Atherectomy Device
    • 7.1.1. Laser Atherectomy
    • 7.1.2. Orbital Atherectomy
    • 7.1.3. Rotational Atherectomy
  • 7.2. Balloon Catheter
    • 7.2.1. Cutting Balloon Catheter
    • 7.2.2. Drug-Coated Balloon Catheter
    • 7.2.3. Standard Balloon Catheter
  • 7.3. Intravascular Imaging System
    • 7.3.1. Fractional Flow Reserve
    • 7.3.2. Intravascular Ultrasound
    • 7.3.3. Optical Coherence Tomography
  • 7.4. Stent Systems
    • 7.4.1. Bare Metal Stent
    • 7.4.2. Drug Eluting Stent

8. Coronary Artery Disease Treatment Devices Market, by Material Composition

  • 8.1. Metals
    • 8.1.1. Stainless Steel
    • 8.1.2. Cobalt-Chromium
    • 8.1.3. Platinum-Chromium
  • 8.2. Polymers
  • 8.3. Bioabsorbable
    • 8.3.1. Magnesium Alloys
    • 8.3.2. Poly-L-lactic Acid

9. Coronary Artery Disease Treatment Devices Market, by Treatment Type

  • 9.1. Coronary Artery Bypass Grafting
    • 9.1.1. Off Pump
    • 9.1.2. On Pump
  • 9.2. Percutaneous Coronary Intervention

10. Coronary Artery Disease Treatment Devices Market, by Approach

  • 10.1. Transfemoral Approach
  • 10.2. Transradial Approach

11. Coronary Artery Disease Treatment Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Centers
  • 11.3. Hospitals & Clinics

12. Coronary Artery Disease Treatment Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Coronary Artery Disease Treatment Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Coronary Artery Disease Treatment Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Abiomed, Inc.
  • 16.3. AngioDynamics, Inc.
  • 16.4. B. Braun Melsungen AG
  • 16.5. Becton, Dickinson and Company
  • 16.6. Biosensors International Group, Ltd.
  • 16.7. Biotronik SE & Co. KG
  • 16.8. Boston Scientific Corporation
  • 16.9. Cardinal Health, Inc.
  • 16.10. Cook Medical Inc.
  • 16.11. Edwards Lifesciences Corporation
  • 16.12. Johnson & Johnson Services Inc.
  • 16.13. Koninklijke Philips N.V.
  • 16.14. Lepu Medical Technology (Beijing) Co., Ltd.
  • 16.15. Medtronic plc
  • 16.16. Meril Life Sciences Pvt. Ltd.
  • 16.17. Merit Medical Systems, Inc.
  • 16.18. MicroPort Scientific Corporation
  • 16.19. Penumbra, Inc.
  • 16.20. Shockwave Medical, Inc.
  • 16.21. Teleflex Incorporated
  • 16.22. Terumo Corporation
  • 16.23. W. L. Gore & Associates, Inc.
  • 16.24. Zylox-Tonbridge Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ATHERECTOMY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ATHERECTOMY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ATHERECTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LASER ATHERECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LASER ATHERECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LASER ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ORBITAL ATHERECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ORBITAL ATHERECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ORBITAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BALLOON CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BALLOON CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CUTTING BALLOON CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CUTTING BALLOON CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CUTTING BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DRUG-COATED BALLOON CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DRUG-COATED BALLOON CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DRUG-COATED BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STANDARD BALLOON CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STANDARD BALLOON CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STANDARD BALLOON CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVASCULAR IMAGING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVASCULAR IMAGING SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVASCULAR IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FRACTIONAL FLOW RESERVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FRACTIONAL FLOW RESERVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FRACTIONAL FLOW RESERVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OPTICAL COHERENCE TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL OPTICAL COHERENCE TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL OPTICAL COHERENCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STENT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STENT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BARE METAL STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BARE METAL STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BARE METAL STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL METALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL METALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL METALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COBALT-CHROMIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COBALT-CHROMIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COBALT-CHROMIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PLATINUM-CHROMIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLATINUM-CHROMIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PLATINUM-CHROMIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOABSORBABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOABSORBABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOABSORBABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAGNESIUM ALLOYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MAGNESIUM ALLOYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAGNESIUM ALLOYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POLY-L-LACTIC ACID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POLY-L-LACTIC ACID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POLY-L-LACTIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL OFF PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL OFF PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL OFF PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ON PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ON PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ON PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TRANSFEMORAL APPROACH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TRANSFEMORAL APPROACH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TRANSFEMORAL APPROACH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL TRANSRADIAL APPROACH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL TRANSRADIAL APPROACH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TRANSRADIAL APPROACH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 201. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 202. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 203. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 207. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 208. GCC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 239. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 240. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 246. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 247. G7 CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 252. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 253. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 254. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 255. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 259. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 260. NATO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 278. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIOABSORBABLE, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2032 (USD MILLION)
  • TABLE 299. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
  • TABLE 300. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICE, 2018-2032 (USD MILLION)
  • TABLE 304. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETER, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR IMAGING SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MA